What is the recommended dosing regimen of ferrous gluconate (ferrous glucose) for adults, children aged 2–12 years, and pregnant women, including frequency, duration of therapy, and management of intolerance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ferrous Gluconate Dosing

Ferrous gluconate 300–325 mg tablets (providing 37–38 mg elemental iron) taken once daily on an empty stomach is the recommended regimen for adults, with pediatric dosing at 2–3 mg/kg/day of elemental iron divided into 2–3 doses, and pregnant women requiring the same adult regimen continued for 3 months after hemoglobin normalizes. 1

Adults

Standard Dosing

  • Administer 50–100 mg elemental iron once daily in the morning, 1–2 hours before meals, on an empty stomach 1
  • Ferrous gluconate contains approximately 37–38 mg elemental iron per 324 mg tablet (11–12% elemental iron by weight), requiring 2–3 tablets daily to achieve the therapeutic target 1
  • Single daily dosing is preferred over divided doses because doses ≥60 mg elemental iron trigger hepcidin elevation for ~24 hours, blocking subsequent iron absorption by 35–45% 1

Alternative Regimen for Intolerance

  • If daily dosing causes intolerable gastrointestinal symptoms, switch to alternate-day dosing (every other day) with 100–200 mg elemental iron, which markedly improves fractional absorption and reduces side effects while preserving efficacy 1

Absorption Enhancement

  • Co-administer 250–500 mg vitamin C to enhance absorption, especially when iron must be taken with food due to intolerance 1
  • Avoid coffee, tea, or calcium-rich foods within 1–2 hours of the iron dose, as these are potent inhibitors of absorption 1
  • Discontinue proton-pump inhibitors and H₂-blockers when possible, as they reduce iron absorption 1

Duration of Therapy

  • Continue oral iron for approximately 3 months after hemoglobin normalizes to fully replenish bone-marrow iron stores 1
  • Check hemoglobin 2–4 weeks after initiating therapy; an increase of ≥10 g/L within 2 weeks predicts successful treatment (sensitivity ≈90%, specificity ≈79%) 1
  • Monitor hemoglobin every 6 months during the first year after treatment completion to detect recurrent iron deficiency 1

Cost Considerations

  • Ferrous gluconate costs approximately $1.50–$3.30 for a 30-tablet supply, making it cost-effective though less concentrated than ferrous sulfate or ferrous fumarate 1
  • The lower elemental iron content per tablet (37 mg vs. 65 mg in ferrous sulfate or 106 mg in ferrous fumarate) requires more tablets to achieve equivalent dosing 1

Children (Ages 2–12 Years)

Standard Pediatric Dosing

  • Administer 2–3 mg/kg/day of elemental iron, divided into 2–3 doses throughout the day 2
  • For a 10 kg child, this translates to 20–30 mg elemental iron daily, which equals approximately 54–81 mg of ferrous gluconate salt per day (roughly 1.5–2 tablets) 2

Treatment of Iron Deficiency Anemia

  • For confirmed iron deficiency anemia, use 3 mg/kg/day of elemental iron given between meals to maximize absorption 2
  • Liquid formulations are more appropriate for young pediatric patients than solid dose forms 2

Administration Guidelines

  • Administer on an empty stomach, as food reduces iron absorption by up to 50% 2
  • Avoid giving iron within 2 hours before or 1 hour after meals 2
  • Separate aluminum-based phosphate binders from iron dosing, as they reduce iron absorption 2

Managing Intolerance

  • If gastrointestinal side effects occur, reduce to smaller, more frequent doses or consider alternate-day dosing rather than discontinuing therapy 2
  • Start with a lower dose and gradually increase to target to improve tolerance 2

Monitoring

  • Recheck hemoglobin after 4 weeks of treatment; if no response despite compliance, further evaluation with MCV, RDW, and serum ferritin is needed 2
  • For children who show no hematologic response after 4 weeks of oral ferrous gluconate despite confirmed adherence, intravenous iron should be considered when malabsorption is suspected 2

Pregnant Women

Dosing Regimen

  • Administer 50–100 mg elemental iron once daily (2–3 ferrous gluconate tablets) on an empty stomach, 1–2 hours before meals 1
  • Liquid ferrous gluconate (75 mg elemental iron per day in 2 vials) was well-tolerated in pregnancy with no reported side effects in clinical trials 3

Efficacy in Pregnancy

  • Oral liquid ferrous gluconate demonstrated significant increases in red blood cells (33%), hemoglobin (32%), hematocrit (32%), and serum iron (61%) after 30 days of treatment in pregnant and postpartum women 3
  • Ferrous gluconate was better tolerated than ferrous sulfate or ferric protein succinylate, with zero dropouts due to side effects compared to 1–2 dropouts in other groups 3

Duration of Therapy

  • Continue iron supplementation throughout pregnancy and for 3 months postpartum to prevent post-natal reduction in hemoglobin and ferritin 3
  • Women who take iron supplements during pregnancy do not suffer the same post-natal reduction in hemoglobin and ferritin as those who don't 3

Common Pitfalls to Avoid

  • Do not prescribe multiple daily doses; this increases side effects (odds ratio 2.32 vs. placebo) without improving absorption due to hepcidin-mediated blockade 1
  • Do not rely on multivitamin preparations for iron repletion, as they contain ≤14 mg elemental iron—insufficient for treating iron-deficiency anemia 1
  • Do not discontinue oral iron when hemoglobin normalizes; continue therapy for an additional 3 months to restore iron stores 1
  • Do not switch between different ferrous salts expecting better tolerability, as evidence does not support this practice 1
  • Do not confuse ferrous gluconate (oral) with ferric gluconate (intravenous), as they have entirely different dosing regimens and indications 4

Indications for Intravenous Iron

  • Switch to IV iron if hemoglobin does not rise after 2–4 weeks of adherent oral therapy; early oral non-responders have only a 21% chance of later response with continued oral iron versus a 65% chance with IV iron 1
  • Use IV iron when gastrointestinal side effects remain intolerable despite dosing adjustments (alternate-day dosing, taking with food, vitamin C co-administration) 1
  • IV iron is indicated in malabsorption syndromes (inflammatory bowel disease, celiac disease, post-bariatric surgery), chronic kidney disease, heart failure, ongoing blood loss exceeding oral replacement capacity, and during the second and third trimesters of pregnancy 1

References

Guideline

Optimal Oral Iron Therapy for Iron‑Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ferrous Fumarate Dosing for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ferric Gluconate Dosing for Severe Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Can a patient take ferrous gluconate (iron supplement) three times a day?
Which is better absorbed, ferrous sulfate or ferrous gluconate?
What is the duration required for ferrous gluconate (iron supplement) 324mg to reach a therapeutic level in patients with iron deficiency anemia?
What is the recommended dose of ferrous gluconate (iron supplement) for adults?
Is ferrous gluconate the same as Palafer (iron supplement)?
What is the appropriate work‑up and treatment for a patient with a serum sodium of 130 mEq/L (mild hyponatraemia)?
What are the indications, recommended oral dosing, administration guidelines, treatment duration, side effect management, alternative formulations, intravenous options, and contraindications for iron supplementation in patients with iron‑deficiency anemia?
For an adult with chronic facial pain currently taking hydrocodone‑acetaminophen 7.5 mg/325 mg several times daily, is oral oxycodone or a transdermal fentanyl patch the more appropriate next step in pain management?
In an octogenarian with chronic back‑spasm pain who is taking hydrocodone/acetaminophen (Norco) and ibuprofen every six hours, how should the medication regimen be optimized for safety and effective pain control?
Is it acceptable to intubate a patient who is not in cardiac arrest without sedation or neuromuscular blockade?
In an HIV‑positive adult already receiving prophylaxis for pneumocystis pneumonia, toxoplasmosis, and Mycobacterium avium complex, how should chronic hepatitis B and hepatitis C be treated while ensuring compatibility with his antiretroviral regimen and avoiding drug‑drug interactions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.